Invitrogen Sets Third Quarter Earnings Release Date for Tuesday, October 21, 2008

  
    
  
  
    
      Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life 
      science technologies for research, production and diagnostics, will 
      announce its third quarter 2008 earnings on Tuesday, October 21, 2008, 
      after Market close. Following the earnings release, Invitrogen senior 
      management will hold a live webcast at 4:30 p.m. EDT to discuss the 
      financial and business results in more detail.
    
    
      The webcast can be accessed on Invitrogen’s 
      Web site at www.invitrogen.com 
      on the Investor Relations home page. Alternatively, callers may listen 
      to the live conference call by dialing 800.299.0433 (domestic) or 
      617.801.9712 (international) and use passcode 59590328. A replay of the 
      webcast will be available on the Company’s 
      website through Tuesday, November 11, 2008.
    
    
      About Invitrogen
    
    
      Invitrogen Corporation (NASDAQ:IVGN) provides products and services that 
      support academic and government research institutions and pharmaceutical 
      and biotech companies worldwide in their efforts to improve the human 
      condition. The company provides essential life science technologies for 
      disease research, drug discovery, and commercial bioproduction. 
      Invitrogen’s own research and development 
      efforts are focused on breakthrough innovation in all major areas of 
      biological discovery including functional genomics, proteomics, stem 
      cells, cell therapy and cell biology – placing 
      Invitrogen’s products in nearly every major 
      laboratory in the world. Founded in 1987, Invitrogen is headquartered in 
      Carlsbad, CA, and conducts business in more than 70 countries around the 
      world. The company employs approximately 4,700 scientists and other 
      professionals and had revenues of approximately $1.3 billion in 2007. 
      For more information, visit www.Invitrogen.com.